Davies K - Search Results

1

"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic.

Gordish-Dressman H, Willmann R, Dalle Pazze L, Kreibich A, van Putten M, Heydemann A, Bogdanik L, Lutz C, Davies K, Demonbreun AR, Duan D, Elsey D, Fukada SI, Girgenrath M, Patrick Gonzalez J, Grounds MD, Nichols A, Partridge T, Passini M, Sanarica F, Schnell FJ, Wells DJ, Yokota T, Young CS, Zhong Z, Spurney C, Spencer M, De Luca A, Nagaraju K, Aartsma-Rus A. Gordish-Dressman H, et al. Among authors: davies k. J Neuromuscul Dis. 2018;5(4):407-417. doi: 10.3233/JND-180324. J Neuromuscul Dis. 2018. PMID: 30198876 Free PMC article.

2

Expression of full-length utrophin prevents muscular dystrophy in mdx mice.

Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. Tinsley J, et al. Among authors: davies k. Nat Med. 1998 Dec;4(12):1441-4. doi: 10.1038/4033. Nat Med. 1998. PMID: 9846586

3

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.

Perkins KJ, Davies KE. Perkins KJ, et al. Neuromuscul Disord. 2002 Oct;12 Suppl 1:S78-89. doi: 10.1016/s0960-8966(02)00087-1. Neuromuscul Disord. 2002. PMID: 12206801 Review.

4

A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.

Weir AP, Morgan JE, Davies KE. Weir AP, et al. Neuromuscul Disord. 2004 Jan;14(1):19-23. doi: 10.1016/j.nmd.2003.09.004. Neuromuscul Disord. 2004. PMID: 14659408

5

Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration.

Yokota T, Lu QL, Morgan JE, Davies KE, Fisher R, Takeda S, Partridge TA. Yokota T, et al. J Cell Sci. 2006 Jul 1;119(Pt 13):2679-87. doi: 10.1242/jcs.03000. Epub 2006 Jun 6. J Cell Sci. 2006. PMID: 16757519

6

Treating muscular dystrophy with stem cells?

Davies KE, Grounds MD. Davies KE, et al. Cell. 2006 Dec 29;127(7):1304-6. doi: 10.1016/j.cell.2006.12.010. Cell. 2006. PMID: 17190595 Free article.

7

The allure of stem cell therapy for muscular dystrophy.

Grounds MD, Davies KE. Grounds MD, et al. Neuromuscul Disord. 2007 Mar;17(3):206-8. doi: 10.1016/j.nmd.2007.01.007. Epub 2007 Feb 15. Neuromuscul Disord. 2007. PMID: 17306535 Review.

8

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.

Baban D, Davies KE. Baban D, et al. Neuromuscul Disord. 2008 Mar;18(3):239-47. doi: 10.1016/j.nmd.2007.11.011. Epub 2008 Mar 14. Neuromuscul Disord. 2008. PMID: 18343112

9

Modified patient stem cells as prelude to autologous treatment of muscular dystrophy.

Davies KE, Grounds MD. Davies KE, et al. Cell Stem Cell. 2007 Dec 13;1(6):595-6. doi: 10.1016/j.stem.2007.11.003. Cell Stem Cell. 2007. PMID: 18371397 Free article. Review.

10

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.

Goyenvalle A, Babbs A, Powell D, Kole R, Fletcher S, Wilton SD, Davies KE. Goyenvalle A, et al. Mol Ther. 2010 Jan;18(1):198-205. doi: 10.1038/mt.2009.248. Epub 2009 Oct 20. Mol Ther. 2010. PMID: 19844193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,554 results

Search Page

Filters